Trending Topic

Breast Cancer
29 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Endocrine therapy (ET) has changed the natural history of hormone receptor-positive (HR+) breast cancer (BC) and is the cornerstone of the treatment of HR+ BC. There are several ETs approved for the treatment of BC, including selective oestrogen receptor modulators (SERMs; tamoxifen), aromatase inhibitors (AIs; anastrazole, letrozole and exemestane) and selective oestrogen receptor degraders (SERDs; fulvestrant […]

Judy Garber, ASCO 2019 – Progress and challenges in clinical cancer genetics

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Jun 11th 2019

Following her Award Lecture, ‘Progress and Challenges in Clinical Cancer Genetics’, Judy Garber further discusses this topic at the ASCO 2019 annual meeting. The progress made in genetic testing and the benefits/challenges that remain are covered.

Questions

1. What progress has been made in genetic testing for cancer susceptibility among individuals at high genetic risk, and what challenges remain? (0:03)
2. How are inherited genetics informing target therapy? (01:21)
3. What other challenges in clinical cancer genetics do you consider important? (02:40)

Speaker disclosure: Judy Garber has nothing to disclose in relation to this video interview.

Filmed at the American Society of Clinical Oncology (ASCO) 2019 Annual Meeting, Chicago, IL, USA.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied

This Functionality is for
Members Only

Explore the latest in medical education and stay current in your field. Create a free account to track your learning.

Close Popup